AR and posterior cortical atrophy: Early-stage PCa typically responds well to androgen deprivation therapy (ADT); however, most advanced cases eventually progress to castration-resistant prostate cancer (CRPC), which relies more heavily on the androgen receptor (AR) signaling pathway [3].